ENTITY
CSL Ltd

CSL Ltd (CSL AU)

172
Analysis
Health Care • Australia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bearish•Macquarie Group
•02 Dec 2015 21:30

Buy Signal for the A$ Weakens as the Currency Remains Resilient in the Face of Commodity Headwinds

Global commodity prices have continued to slide in recent months, with the RBA Commodity Price index down another 5% in US dollar terms. ...

Logo
330 Views
Share
•07 Oct 2015 11:15

Morningstar Healthcare Observer: Biotech Industry Undervalued

The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...

Share
•21 Aug 2015 23:01

Dissecting Quality: When Does Management Quality and Corporate Governance Matter Most?

Most active funds tout their ability to discriminate between good and poor quality management, and accordingly weight their portfolios towards...

Logo
427 Views
Share
bearish•Macroeconomics
•01 Apr 2015 11:31

Taxing Times For Australia

The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...

Logo
6k Views
Share
•05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
439 Views
Share
x